251 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Merck's Keytruda Gets Priority Review in Difficult Lung Cancer http://www.zacks.com/stock/news/310183/mercks-keytruda-gets-priority-review-in-difficult-lung-cancer?cid=CS-ZC-FT-310183 Jul 03, 2018 - Merck's (MRK) sBLA looking to expand the label of Keytruda for first-line treatment of metastatic squamous NSCLC gets FDA's priority review. The decision is expected on Oct 30.
Better Know Biotech: 2 Stocks You've Got to Know About https://www.fool.com/investing/2018/06/01/better-know-biotech-2-stocks-you-better-know-about.aspx?source=iedfolrf0000001 Jun 01, 2018 - These two small-cap biotech stocks could be about to make it big.
Incyte (INCY) Up 10.2% Since Earnings Report: Can It Continue? http://www.zacks.com/stock/news/305890/incyte-incy-up-102-since-earnings-report-can-it-continue?cid=CS-ZC-FT-305890 May 31, 2018 - Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Biotechs With Huge FDA Decisions in June https://www.fool.com/investing/2018/05/31/3-biotechs-with-huge-fda-decisions-in-june.aspx?source=iedfolrf0000001 May 31, 2018 - The clock is ticking for these biotechs hoping to score key regulatory victories.
5 Things AbbVie Investors Need to Know https://www.fool.com/investing/2018/05/18/5-things-abbvie-investors-need-to-know.aspx?source=iedfolrf0000001 May 18, 2018 - AbbVie's top executives answer tough questions about the company's products and pipeline.
A Huge Decision Is on Tap for This Little Biotech Stock https://www.fool.com/investing/2018/05/16/a-huge-decision-is-on-tap-for-this-little-biotech.aspx?source=iedfolrf0000001 May 16, 2018 - A make-it or break-it determination is fast approaching for one tiny clinical-stage company.
Is Agenus Inc. (AGEN) a Buy? https://www.fool.com/investing/2018/05/12/is-agenus-inc-agen-a-buy.aspx?source=iedfolrf0000001 May 12, 2018 - This cancer-focused biotech will take plenty of shots on goal in the years ahead.
Incyte (INCY) Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4168094-incyte-incy-q1-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 01, 2018 - Incyte Corp. (NASDAQ:INCY)Q1 2018 Earnings CallMay 01, 2018 8:00 am ETExecutivesMichael Charles A. Booth - Incyte Corp.Hervé Hoppenot - Incyte Corp.Barry P. Flannelly - Incyte Corp.Steven H. Stein - I
Incyte (INCY) Incurs Loss in Q1, Revenues Miss Estimates http://www.zacks.com/stock/news/301776/incyte-incy-incurs-loss-in-q1-revenues-miss-estimates?cid=CS-ZC-FT-301776 May 01, 2018 - Incyte (INCY) reported disappointing results for the first quarter wherein the company reported a loss against expectation of earnings and sales too missed estimates.
Incyte (INCY) Reports A Loss in Q1 http://www.zacks.com/stock/news/301644/incyte-incy-reports-a-loss-in-q1?cid=CS-ZC-FT-301644 May 01, 2018 - Incyte reported a loss in the first quarter while sales also beat estimates.

Pages: 1...345678910111213...26

<<<Page 8>